When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity Platform
Titel:
When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity Platform
Auteur:
Lotz, Gregor P. Benstein, Karin Bloem, Karien Buddiger, Harm Calonder, Claudio Elm, Stefanie Fernandez, Elena Goodman, Joanne Gorovits, Boris Grudzinska-Goebel, Joanna Janssen, Melody Jawa, Vibha Kramer, Daniel Luo, Linlin Malisauskas, Mantas Michaut, Lydia Schäfer, Martin Spindeldreher, Sebastian Ullmann, Martin Nana Weldingh, Karin Kromminga, Arno Snoeck, Veerle